| Prev Close | 0.38 |
| Open | 0.38 |
| Day Low/High | 0.35 / 0.38 |
| 52 Wk Low/High | 0.20 / 0.64 |
| Volume | 1.32M |
| Avg Volume | 696.10K |
| Exchange | AMEX |
| Shares Outstanding | 3.46M |
| Market Cap | 1.32M |
| EPS | -7.90 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
The Klein Law Firm Reminds Investors Of A Class Action Filed On Behalf Of ImmunoCellular Therapeutics, Ltd. Shareholders And A Lead Plaintiff Deadline Of June 30, 2017
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of ImmunoCellular Therapeutics, Ltd.
ImmunoCellular Therapeutics Announces Data From ICT-121 Phase 1 Trial In Recurrent Glioblastoma At ASCO 2017
ICT-121 Survival Data Encouraging
The Klein Law Firm Notifies Investors Of A Class Action Filed On Behalf Of ImmunoCellular Therapeutics, Ltd. Shareholders And A Lead Plaintiff Deadline Of June 30, 2017
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of ImmunoCellular Therapeutics, Ltd.
IMMUNOCELLULAR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $500,000 In Immunocellular Therapeutics, Ltd. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in ImmunoCellular Therapeutics, Ltd.
IMUC SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving ImmunoCellular Therapeutics, Ltd. And A Lead Plaintiff Deadline Of June 30, 2017
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of investors who purchased ImmunoCellular...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of ImmunoCellular Therapeutics, Ltd. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of June 30, 2017 - IMUC
The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of ImmunoCellular Therapeutics, Ltd.
IMMUNOCELLULAR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In ImmunoCellular Therapeutics, Ltd. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in ImmunoCellular Therapeutics, Ltd.
IMUC EQUITY ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving ImmunoCellular Therapeutics, Ltd. And A Lead Plaintiff Deadline Of June 30, 2017
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of investors who purchased ImmunoCellular...
IMUC LOSS NOTICE: Rosen Law Firm Reminds ImmunoCellular Therapeutics, Ltd. Of Important Deadline In Class Action - IMUC
Rosen Law Firm, a global investor rights law firm, reminds purchasers of ImmunoCellular Therapeutics, Ltd.
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of ImmunoCellular Therapeutics, Ltd. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of June 30, 2017 - IMUC
The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of ImmunoCellular Therapeutics, Ltd.
IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against ImmunoCellular Therapeutics, Ltd. And Encourages Investors With Losses To Contact The Firm
Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against ImmunoCellular Therapeutics, Ltd.
INVESTOR ALERT: Goldberg Law PC Announces The Filing Of A Securities Class Action Lawsuit Against ImmunoCellular Therapeutics, Ltd.
Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against ImmunoCellular Therapeutics, Ltd.
IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against ImmunoCellular Therapeutics, Ltd. And Encourages Investors With Losses To Contact The Firm
Khang & Khang LLP (the "Firm") announces the filing of a class action lawsuit against ImmunoCellular Therapeutics, Ltd.
EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against ImmunoCellular Therapeutics, Ltd. - IMUC
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of ImmunoCellular Therapeutics, Ltd.
For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1
An SEC enforcement action uncovers the deep involvement and brazen misbehavior of biotech CEOs in an illegal stock promotion scheme.
